These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32495885)

  • 1. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
    Gao P; Jiao H; Zhe L; Cui J
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
    Li HP; Yang TZ; Wei L; Ge YF; Meng QS
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
    Zhang Z; Li SY; Zhang LB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FALEC promotes proliferation, migration, and invasion of PTC cells through regulating Wnt/β-catenin signaling pathway.
    Xiao X; Li L; Cui JC; Wang Y
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4361-4367. PubMed ID: 32373973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
    Lv P; Xue Y
    Bioengineered; 2021 Dec; 12(1):3873-3885. PubMed ID: 34281460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linc00324 promotes the progression of papillary thyroid cancer via regulating Notch signaling pathway.
    Wan JF; Wan JY; Dong C; Li L
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6818-6824. PubMed ID: 32633374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
    Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
    Zhu Y; Zhao J; Tan L; Lin S; Long M; Peng X
    Pathol Res Pract; 2021 May; 221():153395. PubMed ID: 33798913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
    Min WP; Wei XF
    Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Liu W; Lin R; Zhu C; Chen Y; Gao Q; Zhong J
    Discov Med; 2024 Sep; 36(188):1819-1830. PubMed ID: 39327245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
    Wang R; Zhao L; Ji L; Bai L; Wen Q
    Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
    Sun YH; Liu ZF; Yang BB; Yu B
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
    Ren P; Zhang H; Chang L; Hong XD; Xing L
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Chen CZ; Wen JL; Lin BY; Zheng C; Quan RD; Zhang XH; Qu JM
    Biomark Med; 2020 Jul; 14(11):969-980. PubMed ID: 32940082
    [No Abstract]   [Full Text] [Related]  

  • 20. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    Zhao M; Yang F; Sang C; Yan C; Wang Z
    J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.